You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 55 No. 10, October 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Abstract
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (133)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Psychiatry, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Role of the Serotonin Transporter Promoter Polymorphism in Anxiety-Related Traits

Chiara M. Mazzanti, PhD; Jaakko Lappalainen, MD, PhD; Jeffrey C. Long, PhD; Dietmar Bengel, MD; Hannu Naukkarinen, MD; Monica Eggert, MD; Matti Virkkunen, MD; Markku Linnoila, MD, PhD; David Goldman, MD

Arch Gen Psychiatry. 1998;55:936-940.

ABSTRACT

Background  The heritability of interindividual variation in anxiety and other aspects of personality establishes that variants of genes influence these traits. A functional polymorphism in the promoter of the human serotonin transporter gene (SLC6A4*C) was identified and found to be linked to an anxiety-related personality trait, Neuroticism. The polymorphism affects gene transcription and, ultimately, gene function. We have attempted to confirm the role of SLC6A4*C in anxiety-related personality traits by sibpair analysis and association studies.

Methods  Sibpair linkage analysis and association study were performed in 655 Finns. The index cases were 182 alcoholic criminal offenders, through which 258 relatives were ascertained to obtain 366 sibpairs. In addition, 215 unrelated population controls were collected. Each individual was psychiatrically interviewed, blind-rated for DSM-III-R diagnoses, and assessed with the Tridimensional Personality Questionnaire.

Results  The sibpair analysis revealed a positive linkage between SLC6A4*C and the 2 anxiety-related subdimensions of Harm Avoidance: HA1 (Anticipatory Worry) and HA2 (Fear of Uncertainty) (P=.003). However, there was no consistent association between SLC6A4*C and any Tridimensional Personality Questionnaire trait.

Conclusions  In the present study we replicated the relationship of SLC6A4*C to anxiety by sibpair linkage analysis but found no evidence of association, raising the question of whether SLC6A4*C locus is itself affecting anxiety or is linked to another still unknown functional variant.



INTRODUCTION
 Jump to Section
 •Top
 •Introduction
 •Subjects and methods
 •Results
 •Comment
 •Author information
 •References

NEUROPHYSIOLOGICAL processes, which are genetically regulated, induce basic personality dimensions that determine inclinations to activate, preserve, or repress specific behaviors within the range available in a given society.1 Variation in personality is one important component of human individuality and this variation is due to the interaction of interindividual differences in genes and environment.2

In the tridimensional theory of personality proposed by Cloninger,3-4 each of 3 personality dimensions is postulated to be related to the primary action of 1 neurotransmitter system: Novelty Seeking (NS) to dopamine activity, Harm Avoidance (HA) to serotonin activity, and Reward Dependence (RD) to norepinephrine activity.5 Among the 3 dimensions, HA is most closely akin to anxiety, being influenced by anxiety state, anxiety trait, and sex.6 Individuals scoring higher than average in HA are characterized by anxiousness and shyness, and high HA scores are found in patients with generalized anxiety disorder.6-9 Involvement of serotonin in HA and anxiety10 is consistent with the positive therapeutic effects of selective serotonin reuptake inhibitors (SSRIs) in both anxiety and depression. The genetic epidemiology of anxiety and depression is consistent with a shared vulnerability for these disorders.11 Although both SSRIs and benzodiazepines are commonly used in the treatment of anxiety, the SSRIs have a wider spectrum of action and are highly effective in depression.

Recently, a functional polymorphism in the human serotonin transporter (SLC6A4) promoter has been described12 and associated by inference to 2 subdimensions of HA, Anticipatory Worry (HA1) and Fear of Uncertainty (HA2), and directly to an equivalent anxiety-related personality trait on the NEO Personality Inventory–Revised: Neuroticism.13 The polymorphism (SLC6A4*C) consists of a repetitive sequence (variable number of tandem repeats), located 1 kilobase upstream of the transcription site. The allele with a smaller number of repeats (SLC6A4*C14) (frequency=0.40) has lower transcriptional activity leading to reductions in messenger RNA levels, serotonin binding, and serotonin reuptake compared with the longer allele (SLC6A4*C16).13-14

In this study, we examined the linkage of the SLC6A4*C locus to anxiety-related traits by performing sibpair analysis and association studies in a population of 655 Finns that included unrelated and related individuals, all of whom were psychiatrically interviewed and evaluated with the Tridimensional Personality Questionnaire (TPQ).


SUBJECTS AND METHODS
 Jump to Section
 •Top
 •Introduction
 •Subjects and methods
 •Results
 •Comment
 •Author information
 •References

SUBJECTS

The sample (n=655) consisted of alcoholic criminal offenders (ACOs), their relatives, and population controls. The index cases were 182 unrelated ACOs who because of the nature of their crimes were remanded to forensic psychiatric examination at the time of their incarceration. In addition, 258 relatives were collected through index cases. Therefore, 366 sibpairs were obtained and consisted of some of the index cases (ACOs) and their non-ACO sibs, so the sibpairs did not necessarily involve 1 ACO as in families with more than 2 children. The population control sample consisted of 215 nonrelated psychiatrically interviewed Finnish volunteers who were recruited by advertisement and paid for their participation. The Structured Clinical Interview for DSM-IV (SCID) was administered by 2 psychiatrists (H.N. and M.E.). Psychiatric diagnoses and TPQ scores were ascertained blind to subject identities and history. Alcoholism was defined by DSM-III-R criteria for alcohol dependence or alcohol abuse.15

All subjects provided an informed written consent before entering the study. This protocol was approved by the Institutional Review Boards of the National Institutes of Health and the National Institute of Mental Health, Rockville, Md, of the Department of Psychiatry, University of Helsinki and of the University of Helsinki Central Hospital, Helsinki, Finland, and by the Office for Protection from Research Risks, Bethesda, Md.

TPQ TRAITS

The TPQ measures 3 higher-order personality dimensions.3-4 These 3 personality dimensions are Novelty Seeking (NS), Harm Avoidance (HA), and Reward Dependence (RD), each of which is divided into 4 subdimensions as given in Table 1. High NS is a heritable tendency toward frequent exploratory activity and excitement in response to novel stimuli. High HA refers to the tendency to avoid situations likely related to punishment. High RD reflects a need for constant reassurance and positive reinforcement.


View this table:
[in this window]
[in a new window]
Table 1. Sibpair Linkage Analysis of SLC6A4*C and Tridimensional Personality Questionnaire Dimensions and Subdimensions*


POLYMERASE CHAIN REACTION (PCR)

The genomic DNA was isolated from Epstein-Barr virus—immortalized lymphoblastoma cell lines. DNA amplification was accomplished using the 2 flanking primers suggested in 1996 by Heils et al12: 5-HTTU:5'GGCGTTGCCGCTCTUAATGC3', nt-1416,-1397 5-HTTL:5'GAGGGACTGAGCTGGACAACCAC, nt-910,-889. This set of primers amplifies a 484/528 fragment corresponding to the SLC6A4*C short and long allele, respectively. The PCR conditions were slightly modified from Heils et al. The PCR reaction was carried out in a total volume of 20 µL consisting of 100 ng of genomic DNA, 0.1 µmol of primers per liter, 40-µmol/L deoxynucleotide triphosphates, 20-µmol/L 7-deaza-2'deoxyguanosine, and 1 unit of AmpliTaq with the appropriate buffer (Perkin-Elmer Biosystem, Foster City, Calif). To enhance the specificity and sensitivity of DNA amplification, TaqStart (Clontech, Palo Alto, Calif), a neutralizing monoclonal antibody directed against Taq DNA polymerase, was added so that HotStart-PCR could be performed. Cycling conditions were as follows: 1 denaturing cycle at 95°C for 5 minutes, 2 cycles with a touchdown annealing temperature of 63°C and 62°C, respectively for 30 seconds, and 38 cycles with an annealing temperature at 61°C. Final DNA elongation was at 72°C for 10 minutes. DNA bands were visualized in prestained (0.4-µg/mL ethidium bromide) 2% agarose gels that were run for 1 hour at 120 V.

STATISTICAL ANALYSIS

Linkage analysis was conducted using the Haseman-Elston sibpair method.16 The Haseman-Elston approach evaluates allele sharing by sibpairs for a polymorphic marker (as in this case the SLC6A4*C ). At the locus of interest, the sibpairs share 0, 1, or 2 alleles identical by descent (IBD) (direct inheritance of copies of the same parental allele). The P values for sibpair linkage analysis are obtained by regression analysis of the squared trait difference {Delta}2 between each pair of siblings vs the number of alleles shared, IBD: 0, 1, or 2. For linkage, a negative slope is expected because siblings who resemble each other in the trait of interest tend to share alleles that are IBD.16-18 Because the accuracy of sibpair analysis depends on large sample approximations, P values were verified by computer simulations. While holding the phenotype, family structures, and genotype distribution constant, the different SLC6A4*C alleles were randomly assigned to the founders of the pedigrees based on their population frequencies. These simulated genotypes were randomly transmitted to the offspring and analyzed for sibpair linkage using the SAGE (Statistical Analysis for Genetic Epidemiology) sibpal module.19 By replicating this procedure 12000 times, a new empirical distribution was created that was used to obtain simulation-derived P values.

Association studies are most powerful when applied to functionally significant variations in genes having a clear biological relation to the trait. Most often, a case-control comparison is performed in which genotype or allele frequencies are compared in groups that differ in affectation.18 Here we compare different genotype groups for a difference in a continuous variable. P values were obtained using 1-way analysis of variance.


RESULTS
 Jump to Section
 •Top
 •Introduction
 •Subjects and methods
 •Results
 •Comment
 •Author information
 •References

Linkage of SLC6A4*C to TPQ personality dimensions was evaluated in 366 sibpairs. As given in Table 1, the SLC6A4*C locus was strongly linked to the 2 anxiety-related subdimensions, HA1 (Anticipatory Worry, P=.003) and HA2 (Fear of Uncertainty, P=.003). These significant P values were verified by computer simulations but were not corrected for multiple analyses because the prior hypothesis was that the SLC6A4*C polymorphism contributes to anxiety-related traits, in particular HA1 and HA2.13 Linkage to the other domains of personality assessed by the TPQ was also evaluated in exploratory analyses. None showed evidence of linkage (Table 1).

Association study of SLC6A4*C to TPQ personality dimensions was tested in 215 unrelated Finnish controls, in 182 unrelated Finnish ACOs, in the total unrelated sample (n=397) (Table 2 and Table 3). Neither HA1 nor HA2 showed a significant association. In exploratory analyses, NS1 (exploratory excitability vs stoic rigidity) and NS total did show P values of P=.03 and =.04, respectively, in unrelated controls (Table 2). Also, RD3 (attachment vs detachment) and RD total showed P values of P=.01 and =.03, respectively, in unrelated ACOs (Table 2) and P=.009 in controls + ACOs (Table 3). However, since there was no prior hypothesis that these traits were affected by SLC6A4*C, these results would not withstand correction for multiple testing.


View this table:
[in this window]
[in a new window]
Table 2. Population Association Study Between SLC6A4*C and Tridimensional Personality Questionnaire Dimensions and Subdimensions*



View this table:
[in this window]
[in a new window]
Table 3. Population Association Study Between SLC6A4*C and Tridimensional Personality Questionnaire Dimensions and Subdimensions*



COMMENT
 Jump to Section
 •Top
 •Introduction
 •Subjects and methods
 •Results
 •Comment
 •Author information
 •References

Harm Avoidance reflects a tendency to respond more intensely to aversive stimuli. People with high HA scores are more fatiguable, shy and anxious with strangers, and tend to worry and become tense in unfamiliar situations.5, 7 It has been suggested that variations in serotonin function in the septohippocampal system are involved in increased HA and in anxiety.4, 10

The serotonin transporter plays a crucial role in the regulation of serotonin neurotransmission by terminating the action of serotonin in the synapse and is the site of action of the SSRIs, used in the treatment of both depression and anxiety. The discovery that a functional serotonin transporter polymorphism was linked to anxiety and a possible association of another serotonin transporter marker to depression were therefore consonant with current knowledge of the origins and molecular targets for treatment of anxiety and depression.13, 20 In the present study, we were able to replicate the relationship of SLC6A4*C to anxiety (HA1 and HA2) by sibpair linkage analysis but found no evidence of significant association.

Sibpair analysis is an allele-sharing method that involves testing under random mendelian segregation whether affected relatives inherit a region IBD from their parents more often than expected. Siblings share an IBD linkage in either 0, 1, or 2 alleles at any autosomal locus, allowing a test of a locus' effect on any trait by regression analysis. On the other hand, valid associations are detected either when the allele is in linkage disequilibrium to a functional allele at a nearby locus or when the allele itself influences the trait. Association studies are therefore identity by state analyses and it can be seen that they are most powerful when applied to functionally significant variations in genes that have a clear biological relationship to the trait.18

In view of the functional importance of SLC6A4*C, we were therefore somewhat surprised to observe IBD linkage without identity by state association. Since the sibpairs also included individuals who were ACOs, we also conducted a sibpair linkage analysis to DSM-III-R alcoholism, but we did not detect linkage (data not shown). In this way, we can rule out the possibility that we have actually detected a linkage to alcoholism instead of to HA. However, there are other possible explanations why the IBD linkage analysis may have had more power to detect an effect of SLC6A4*C than did the association design. Sibpairs may offer an advantage in the detection of allele effects on phenotypes of complex genetic and environmental origins such as TPQ traits. In sibpairs, much of the environment is shared and 50% of the background genotype is held constant. Moreover it may also be that the number of individuals studied is still too small. Consistent with results from previous studies,13 individuals homozygous or heterozygous for SLC6A4*14 scored higher in HA1 and HA2 compared with SLC6A4*16 homozygotes. Finally the serotonin transporter promoter polymorphism could be linked to another nearby functional locus whose effect is detected by sibpair linkage analysis but not by the association design.


AUTHOR INFORMATION
 Jump to Section
 •Top
 •Introduction
 •Subjects and methods
 •Results
 •Comment
 •Author information
 •References

Accepted for publication June 30, 1998.

Some of the results in this study were obtained by using the software program package SAGE, which is supported by US Public Health Service Resource grant 1 P41 RR03655 from the National Center for Research Resources, Bethesda, Md.

We would like to thank Longina Akhtar for her excellent technical assistance. We also appreciate helpful discussions with Dean Hamer, National Cancer Institute, Bethesda, Md, and thank his staff for giving us some precious advice for optimizimizing the SLC6A4*C analyses.

Corresponding author: David Goldman, MD, Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, 12420 Parklawn Dr, Park 5 Bldg, Room 451, Rockville, MD 20852 (e-mail: dgneuro{at}box-d.nih.gov).

From the Laboratory of Neurogenetics (Drs Mazzanti and Goldman), Section of Population Genetics and Linkage (Drs Lappalainen and Long), Laboratory of Clinical Studies (Dr Linnoila), National Institute of Alcohol Abuse and Alcoholism, National Institutes of Health, Rockville, Md; Department of Psychiatry (Drs Naukkarinen, Eggert, and Virkkunen), University of Helsinki, Helsinki, Finland; and Laboratory of Clinical Science (Dr Bengel), National Institute of Mental Health, National Institutes of Health, Bethesda, Md. Dr Linnoila is deceased.


REFERENCES
 Jump to Section
 •Top
 •Introduction
 •Subjects and methods
 •Results
 •Comment
 •Author information
 •References

1. Cloninger CR, Przybeck TR, Svrakic DM. The Tridimensional Personality Questionnaire: U.S. normative data. Psychol Rep. 1991;69:1047-1057. FULL TEXT | ISI | PUBMED
2. Eaves L, Eysenck HJ. The nature of extraversion: a genetical analysis. J Pers Soc Psychol. 1975;32:102-112. FULL TEXT | ISI | PUBMED
3. Cloninger CR. A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatr Dev. 1986;4:167-226. ISI | PUBMED
4. Cloninger CR. A systematic method for clinical description and classification of personality variants. Arch Gen Psychiatry. 1987;44:573-588. FREE FULL TEXT
5. Joffe RT, Bagby RM, Levitt AJ, Regan JJ, Parker JDA. The Tridimensional Personality Questionnaire in Major Depression. Am J Psychiatry. 1993;150:959-960. FREE FULL TEXT
6. Meszaros K, Willinger U, Fischer G, Schönbeck G, Aschauer HN European Fluvoxamine in Alcoholism Study Group. The tridimensional personality model: influencing variables in a sample of detoxified alcohol dependents. Compr Psychiatry. 1996;37:109-114. FULL TEXT | ISI | PUBMED
7. Brown SL, Svrakic MD, Przybeck TR, Cloninger CR. The relationship of personality to mood and anxiety states: a dimensional approach. J Psychiatr Res. 1992;26:197-211. FULL TEXT | ISI | PUBMED
8. Starcevic V, Uhlenhuth EH, Fallon S, Pathak D. Personality dimensions in panic disorder and generalized anxiety disorder. J Affect Disord. 1996;37:75-79. FULL TEXT | ISI | PUBMED
9. Svrakic MD, Przybeck TR, Cloninger CR. Mood states and personality traits. J Affect Disord. 1992;24:217-226. FULL TEXT | ISI | PUBMED
10. Handley SL. 5-Hydroxytryptamine pathways in anxiety and its treatment. Pharmacol Ther. 1995;66:103-148. FULL TEXT | ISI | PUBMED
11. Kendler KS. The genetic epidemiology of psychiatric disorders: a current perspective. Soc Psychiatry Psychiatr Epidemiol. 1997;32:5-11. FULL TEXT | ISI | PUBMED
12. Heils A, Teufel A, Petri S, Seemann M, Stöber G, Riederer P, Bengel D, Lesch KP. Allelic variation of human serotonin transporter gene expression. J Neurochem. 1996;66:2621-2624. ISI | PUBMED
13. Lesch PK, Bengel D, Heils A, Sabol SZ, Greenberg BG, Petri S, Benjamin J, Müller CR, Hamer DH, Murphy DL. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274:1527-1531. FREE FULL TEXT
14. Collier DA, Stöber G, Li T, Heils A, Catalano M, Di Bella D, Arranz MJ, Murray RM, Vallada HP, Bengel D, Müller CR, Roberts GW, Smeraldi E, Kirov G, Sham P, Lesch KP. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry. 1996;1:453-460. ISI | PUBMED
15. Spitzer RL, Endicott J, Robins E. Research Diagnostic Criteria (RDC) for a Selected Group of Functional Disorders. New York, NY: Dept of Research Assessment and Training, New York Psychiatric Institute; 1989:1-40.
16. Haseman JK, Elston RC. The investigation of linkage between a quantitative trait and a marker locus. Behav Genet. 1972;2:3-19. FULL TEXT | ISI | PUBMED
17. Thompson EA, Deep S, Walker D, Motulsky A. The detection of linkage disequilibrium between closely linked markers: RFLPs at the A1-CIII apolipoprotein genes. Am J Hum Genet. 1988;42:113-124. ISI | PUBMED
18. Lander ES, Schork NJ. Genetic dissection of complex trait. Science. 1994;265:2037-2047. FREE FULL TEXT
19. SAGE, Statistical Analysis for Genetic Epidemiology [computer program]. Release 2.2. New Orleans, La: Dept of Biometry and Genetics, Louisiana State University Medical Center; 1994.
20. Ogilvie AD, Battersby S, Bubb VJ, Fink G, Harmar AJ, Goodwin GM, Smith CA. Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet. 1996;347:731-733. FULL TEXT | ISI | PUBMED


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin.
McCaffery et al.
Psychosom. Med. 2006;68:187-200.
ABSTRACT | FULL TEXT  

A Functional Genetic Variation of the Serotonin (5-HT) Transporter Affects 5-HT1A Receptor Binding in Humans
David et al.
J. Neurosci. 2005;25:2586-2590.
ABSTRACT | FULL TEXT  

A Susceptibility Gene for Affective Disorders and the Response of the Human Amygdala
Hariri et al.
Arch Gen Psychiatry 2005;62:146-152.
ABSTRACT | FULL TEXT  

Interaction Between Serotonin Transporter Gene Variation and Rearing Condition in Alcohol Preference and Consumption in Female Primates
Barr et al.
Arch Gen Psychiatry 2004;61:1146-1152.
ABSTRACT | FULL TEXT  

Sexual dichotomy of an interaction between early adversity and the serotonin transporter gene promoter variant in rhesus macaques
Barr et al.
Proc. Natl. Acad. Sci. USA 2004;101:12358-12363.
ABSTRACT | FULL TEXT  

Serotonin Transporter: Gene, Genetic Disorders, and Pharmacogenetics
Murphy et al.
Mol. Interv. 2004;4:109-123.
ABSTRACT | FULL TEXT  

A Polymorphism in the Serotonin Receptor 3A (HTR3A) Gene and Its Association With Harm Avoidance in Women
Melke et al.
Arch Gen Psychiatry 2003;60:1017-1023.
ABSTRACT | FULL TEXT  

Association Between Serotonin Transporter Gene Promoter Polymorphism (5HTTLPR) and Behavioral Responses to Tryptophan Depletion in Healthy Women With and Without Family History of Depression
Neumeister et al.
Arch Gen Psychiatry 2002;59:613-620.
ABSTRACT | FULL TEXT  

Reduction in the Density and Expression, But Not G-Protein Coupling, of Serotonin Receptors (5-HT1A) in 5-HT Transporter Knock-Out Mice: Gender and Brain Region Differences
Li et al.
J. Neurosci. 2000;20:7888-7895.
ABSTRACT | FULL TEXT  

Do the Dimensions of the Temperament and Character Inventory Map a Simple Genetic Architecture? Evidence From Molecular Genetics and Factor Analysis
Herbst et al.
Am. J. Psychiatry 2000;157:1285-1290.
ABSTRACT | FULL TEXT  

Association between Serotonin Transporter Gene Polymorphism and Smoking among Japanese Males
Ishikawa et al.
Cancer Epidemiol. Biomarkers Prev. 1999;8:831-833.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.